D-1090-2023 Class II Terminated

Recalled by Parker Laboratories, Inc. — Fairfield, NJ

FDA drug recall D-1090-2023 was initiated by Parker Laboratories, Inc. on August 2, 2023 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated June 3, 2024). Affected quantity: 250.

Recall Details

Product Type
Drugs
Report Date
August 30, 2023
Initiation Date
August 2, 2023
Termination Date
June 3, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
250

Product Description

Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-on (NDC 30775-051-03), c) 4 fl. oz. tubes (NDC 30775-051-04), d) 12 fl oz pump bottles (NDC 30775-051-12), e) 32 fl. oz. pump bottles (NDC 30775-051-32), f) 1 U.S. gallon with pump (NDC 30775-051-50), g) Starter Kit (NDC 30775-051-95), Parker Laboratories, Inc. 286 Eldridge Road Fairfield, NJ 07004

Reason for Recall

CGMP Deviations

Distribution Pattern

Nationwide within the United States, Singapore, Korea and Hong Kong

Code Information

a) J0721010, Exp. Date 6/30/2024; J1022017, Exp. Date 10/27/2025; b) A0521002, Exp. Date 4/29/2024; c) A0322006, Exp. Date 3/2/2025, A0323004, Exp. Date 2/24/2026, A0422005, Exp. Date 3/14/2025, A0521001, Exp. Date 4/29/2024, A0822004, Exp. Date 7/27/2025, d) C0222001, Exp. Date 6/30/2023, C0521003, Exp. Date 4/29/2023, C0822005, Exp. Date 7/27/2024, e)C0721019, Exp. Date 6/30/2024, f) C0521001, Exp. Date 4/29/2024, C0721022, Exp. Date 6/30/2024, C0822006, Exp. Date 7/27/2025, g) C0323006, C0821022, C0922006, Exp. Date 4/29/2024, C1221003, Exp. Date 4/09/2024